List of Excipients in API gentamicin sulfate cream 0.1%
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing gentamicin sulfate cream 0.1%
Detailed excipient profiles for gentamicin sulfate cream 0.1%
Excipient focus: BUTYLPARABEN
gentamicin sulfate cream 0.1% drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
gentamicin sulfate cream 0.1% drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
gentamicin sulfate cream 0.1% drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 40
gentamicin sulfate cream 0.1% drug variants containing POLYSORBATE 40
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing POLYSORBATE 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
gentamicin sulfate cream 0.1% drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL MONOPALMITOSTEARATE
gentamicin sulfate cream 0.1% drug variants containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
gentamicin sulfate cream 0.1% drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
gentamicin sulfate cream 0.1% drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
gentamicin sulfate cream 0.1% drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sola Pharmaceuticals | gentamicin sulfate cream 0.1% | 70512-036 |
| >Company | >Ingredient | >NDC |
gentamicin sulfate cream 0.1% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch